Copy For Citation
UYAROĞLU O. A., ŞENER Y. Z., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., ŞAHİN T. K., ...More
European Journal of Therapeutics, vol.27, no.4, pp.311-317, 2021 (ESCI)
-
Publication Type:
Article / Article
-
Volume:
27
Issue:
4
-
Publication Date:
2021
-
Doi Number:
10.5152/eurjther.2021.21022
-
Journal Name:
European Journal of Therapeutics
-
Journal Indexes:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.311-317
-
Keywords:
COVID-19, corrected QT, hydroxychloroquine, azithromycin, favipiravir, RISK
-
Hacettepe University Affiliated:
Yes
Abstract
Objective: We aimed to evaluate the degree of QTc prolongation and associated factors in patients with COVID-19 in association with their usage of hydroxychloroquine (HCQ) with or without the combination of azithromycin (AZ) and/or favipiravir (FAV).